2024
Optimizing Opioid Prescription Quantity After Cesarean Delivery
Smid M, Clifton R, Rood K, Srinivas S, Simhan H, Casey B, Longo M, Landau R, MacPherson C, Bartholomew A, Sowles A, Reddy U, Rouse D, Bailit J, Thorp J, Chauhan S, Saade G, Grobman W, Macones G. Optimizing Opioid Prescription Quantity After Cesarean Delivery. Obstetrics And Gynecology 2024, 144: 195-205. PMID: 38857509, PMCID: PMC11257794, DOI: 10.1097/aog.0000000000005649.Peer-Reviewed Original ResearchOpioid tabletsCesarean birthOpioid useHuman Development Maternal-Fetal Medicine Units NetworkMaternal-Fetal Medicine Units NetworkPrimary outcomeQuantity of opioid tabletsEunice Kennedy Shriver National Institute of Child HealthOpioid prescription protocolPostcesarean pain managementHistory of opioid useOpioid prescription quantitiesRandomized controlled noninferiority trialNational Institute of Child HealthInstitute of Child HealthPostcesarean analgesiaCesarean deliveryRandomized controlled trialsPain managementPrescription quantitiesFollow-upWeeks postdischargeNoninferiority trialDecision makingChild health
2017
Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes
Reddy U, Davis J, Ren Z, Greene M. Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes. Obstetrical & Gynecological Survey 2017, 72: 703-705. DOI: 10.1097/ogx.0000000000000517.Peer-Reviewed Original ResearchNeonatal abstinence syndromeOpioid useAbstinence syndromeChildhood outcomesEunice Kennedy Shriver National InstituteOpioid use disorderMaternal-fetal medicineMarch of DimesAffected womenAmerican CollegeChild healthUse disordersAmerican AcademyDisease controlPregnancyNational InstituteSyndromeOutcomesGynecologistsObstetriciansPediatricsPreventionWomen